Public Profile

Shield Pharmaceuticals Corp

Shield Pharmaceuticals Corp., headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in 2005, the company has achieved significant milestones, including the launch of several core products that address critical medical needs. With a focus on therapeutic areas such as oncology and infectious diseases, Shield Pharmaceuticals distinguishes itself through its commitment to research and development, ensuring that its offerings are both effective and safe. The company has established a strong market position, recognised for its high-quality formulations and patient-centric approach. As it continues to expand its operational reach, Shield Pharmaceuticals remains dedicated to improving health outcomes globally.

DitchCarbon Score

How does Shield Pharmaceuticals Corp's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Shield Pharmaceuticals Corp's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

Shield Pharmaceuticals Corp's reported carbon emissions

Shield Pharmaceuticals Corp, headquartered in the US, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprint. However, without specific commitments or initiatives from Shield Pharmaceuticals Corp, it remains unclear how they are addressing climate change and carbon emissions within their operations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Shield Pharmaceuticals Corp's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Shield Pharmaceuticals Corp is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Shield Pharmaceuticals Corp is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

GENCO

US
Health Services
Updated 10 days ago

MN Egypt

EG
Health Services
Updated 11 days ago

Beston Machinery

ES
Health Services
Updated 11 days ago
CDP

Howorth Air Tech

GB
Health Services
Updated 11 days ago

Rafarm

GR
Health Services
Updated 11 days ago
CDP

Saifu Chemical Development Co. Ltd.

CN
Health Services
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers